This inventor holds 1 USPTO granted patent and 10 published patent applications. Top assignee: Astellas Pharma Gmbh. Active years: 2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2016
Title: The Innovative Mind of Atsushi Muro
Introduction
Atsushi Muro is an accomplished inventor based in Tokyo, Japan, with a significant contribution to the field of pharmaceuticals. Through his innovative approach, he has developed a notable patent that highlights his expertise and dedication to advancing medical solutions.
Latest Patents
Atsushi Muro holds one patent for a pharmaceutical composition designed for oral administration. This composition features the active ingredient 4-{[(1R,2S,3S,5S,7S)-5-hydroxy-2-adamantyl]amino}-1H-pyrrolo[2,3-b]pyridine-5-carboxamide, known for its distinct solubility properties in varying pH levels. The invention promises rapid disintegration and drug dissolution, thereby enhancing dosing compliance for patients, which is critical in pharmaceutical applications.
Career Highlights
Atsushi is currently employed by Astellas Pharma GmbH, a renowned company in the pharmaceutical industry. His role there has allowed him to leverage his skills and creativity, resulting in impactful contributions that bridge scientific research and practical medical solutions.
Collaborations
Throughout his career, Atsushi Muro has collaborated with notable colleagues including Seiji Takae and Hiroyuki Kojima. These partnerships have played a significant role in cultivating a productive research environment, enabling the creation of effective pharmaceutical innovations.
Conclusion
With his unique patent and collaborative spirit, Atsushi Muro stands out as an inventive force in the pharmaceutical field. His work at Astellas Pharma GmbH showcases his commitment to enhancing drug delivery systems, ultimately contributing to improved health outcomes for patients. Through innovation and teamwork, Muro continues to shape the future of pharmaceutical compositions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
